Laurus Labs
Serene Chambers, 2nd Floor
Road No. 7, Banjara Hills
Hyderabad
500034
Tel: 91-40-3980-4333
Fax: 91-40-3980-4320
Website: http://www.lauruslabs.com/
About Laurus Labs
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas.YEAR FOUNDED:
2005
LEADERSHIP:
CEO: Satyanarayana Chava
FOLLOW LAURUS LABS:
Tweets by Laurus Labs
4 articles about Laurus Labs
-
CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited
10/23/2018
The drug, tenofovir disoproxil fumarate (TDF), is indicated for the treatment of hepatitis B virus (HBV).
-
Laurus Labs PAT Grows By 40%; Board Recommends A Dividend Of 15%
5/19/2017
-
Company Profile For Laurus Labs
5/19/2017
-
Laurus Labs Demonstrates Strong Q3 Growth In The First Quarterly Results After Successful IPO
2/9/2017